Financial Information

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 31, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-025588.pdf 0001213900-23-025588.rtf 0001213900-23-025588.xls View HTML
Mar 31, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	0001213900-23-025649.pdf 0001213900-23-025649.rtf 0001213900-23-025649.xls View HTML
Mar 28, 2023	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	0001213900-23-023749.pdf 0001213900-23-023749.rtf 0001213900-23-023749.xls View HTML
Mar 10, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-019117.pdf 0001213900-23-019117.rtf 0001213900-23-019117.xls View HTML
Mar 02, 2023	CB	CB	Other	0001213900-23-016804.pdf 0001213900-23-016804.rtf 0001213900-23-016804.xls View HTML
Mar 02, 2023	F-X	F-X	Other	0001213900-23-016813.pdf 0001213900-23-016813.rtf 0001213900-23-016813.xls View HTML
Feb 21, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-013271.pdf 0001213900-23-013271.rtf 0001213900-23-013271.xls View HTML
Feb 10, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	0001493152-23-004276.pdf 0001493152-23-004276.rtf 0001493152-23-004276.xls View HTML
Feb 08, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-009144.pdf 0001213900-23-009144.rtf 0001213900-23-009144.xls View HTML
Jan 24, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-004609.pdf 0001213900-23-004609.rtf 0001213900-23-004609.xls View HTML

Data provided by Kaleidoscope.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.